Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Roche will pay $2.4 billion to acquire the portion of genomic profiling firm Foundation Medicine that it doesn’t already own. Foundation develops tests that pinpoint the genetic defect driving a person’s cancer, allowing tailored treatments. Roche bought a majority stake in the firm in early 2015 for $1.3 billion. The deals dovetail with Roche’s strategy to focus on personalized health care. Foundation will operate as a separate entity.
This article has been sent to the following recipient: